Country for PR: Hong Kong
Contributor: PR Newswire Asia (Hong Kong)
Thursday, July 01 2021 - 10:00
AsiaNet
Zimmer Biomet announces partnership with OSSIS as exclusive Asia Pacific distributor for patient-specific 3D printed titanium hip replacement joints
SINGAPORE, July 1, 2021 /PRNewswire-AsiaNet/ --

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in 
musculoskeletal healthcare, today announced a partnership with OSSIS to serve 
as the exclusive Asia Pacific distributor for its patient-specific 3D printed 
titanium hip replacement joints.

OSSIS, a New Zealand based company, specializes in complex hip replacements 
including second-time hip replacement, and replacement involving bone tumours 
and trauma.

"This partnership will allow Zimmer Biomet to provide our extensive network of 
orthopaedic surgeons with the option of patient-specific implants which are 
crafted with a combination of clinical and engineering expertise," said Sang 
Yi, Zimmer Biomet Asia Pacific Group President. "This will further strengthen 
Zimmer Biomet's extensive portfolio of revision hip solutions and complementary 
technologies, with the ultimate goal of providing innovative solutions for 
complex cases and improving the quality of life of patients."

"The partnership with Zimmer Biomet will enhance OSSIS' ability to support 
surgeons and patients alike and create a network across the Asia Pacific region 
of cutting-edge technology and expert capability," said OSSIS Managing 
Director, Kelvin Hyland. "This is an exciting step for OSSIS. Zimmer Biomet 
shares our ethos of innovative technology, patient-specific solutions and 
proven results."

About Zimmer Biomet 

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global 
leader in musculoskeletal healthcare. We design, manufacture and market 
orthopaedic reconstructive products; sports medicine, biologics, extremities 
and trauma products; office-based technologies; spine, craniomaxillofacial and 
thoracic products; dental implants; and related surgical products.

We collaborate with healthcare professionals around the globe to advance the 
pace of innovation. Our products and solutions help treat patients suffering 
from disorders of, or injuries to, bones, joints or supporting soft tissues. 
Together with healthcare professionals, we help millions of people live better 
lives.

We have operations in more than 25 countries around the world and sell products 
in more than 100 countries. For more information, visit www.zimmerbiomet.com or 
follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.

SOURCE Zimmer Biomet
Translations

Japanese